Breaking News Instant updates and real-time market news.

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

, CHEF

Chefs' Warehouse

$19.45

-0.75 (-3.71%)

19:41
02/20/18
02/20
19:41
02/20/18
19:41

On The Fly: After Hours Movers

UP AFTER EARNINGS: Verisk Analytics (VRSK), up 4.23%... The Chefs' Warehouse (CHEF), up 3.86%... Fluor (FLR), up 1.4%. ALSO HIGHER: RAIT Financial Trust (RAS), up 7% after concluding its strategic and alternative review process... Evans Bancorp (EVBN), up 3.8% after raising its semi-annual dividend 15% to 46c per share. DOWN AFTER EARNINGS: Cardtronics (CATM), down 12.11%... LendingClub (LC), down 10.9% Boyd Gaming (BYD), down 6.17%... Texas Roadhouse (TXRH), down 2.74%. ALSO LOWER: Portola Pharmaceuticals (PTLA), down 8.75% after the Committee for Medicinal Products for Human Use of the European Medicines Agency has communicated a positive trend vote on the Marketing Authorisation Application for andexanet alfa, a Factor Xa-inhibitor reversal agent, and a negative trend vote for betrixaban, an oral, once-daily Factor Xa inhibitor.

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

CHEF

Chefs' Warehouse

$19.45

-0.75 (-3.71%)

FLR

Fluor

$58.04

0.41 (0.71%)

RAS

RAIT Financial

$0.44

-0.031 (-6.56%)

EVBN

Evans Bancorp

$40.95

-1.55 (-3.65%)

CATM

Cardtronics

$24.69

-0.59 (-2.33%)

LC

LendingClub

$4.13

0.18 (4.56%)

BYD

Boyd Gaming

$37.60

0.26 (0.70%)

TXRH

Texas Roadhouse

$56.91

-1.07 (-1.85%)

PTLA

Portola Pharmaceuticals

$48.22

0.53 (1.11%)

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 15

    Mar

  • 04

    May

VRSK Verisk Analytics
$97.04

-1.75 (-1.77%)

01/19/18
RBCM
01/19/18
NO CHANGE
Target $100
RBCM
Sector Perform
Verisk Analytics price target raised to $100 from $90 at RBC Capital
RBC Capital analyst Gary Bisbee raised his price target on Verisk Analytics to $100, forecasting a 6.5% reduction in 2018 effective tax rate that will boost this year's EPS by about 9%. Bisbee adds that he continues to "admire Verisk's valuable proprietary data assets and business model" while forecasting revenue growth to moderately improve in the next few quarters. The analyst says the current valuation justifies the company's current Sector Perform rating.
08/03/17
FBCO
08/03/17
NO CHANGE
Target $85
FBCO
Neutral
Verisk Analytics price target raised to $85 from $80 at Credit Suisse
Credit Suisse analyst Anjaneya Singh raised his price target for Verisk Analytics to $85 from $80 following quarterly results. The analyst reiterates a Neutral rating on the shares.
11/08/17
GSCO
11/08/17
INITIATION
Target $89
GSCO
Neutral
Verisk Analytics initiated with a Neutral at Goldman Sachs
Goldman analyst George Tong initiated Verisk Analytics with a Neutral and $89 price target telling investors revenue softness in the energy and financial services sector, combined with elevated investment spending, will pressure earnings growth.
11/02/17
BMOC
11/02/17
NO CHANGE
Target $91
BMOC
Market Perform
Verisk Analytics price target raised to $91 from $83 at BMO Capital
BMO Capital analyst Jeffrey Silber raised his price target on Verisk Analytics to $91 following Q3 EPS beat that was driven by better-than-expected growth in the Insurance vertical as a result of hurricane-related demand. The analyst says the company's financial services are on track for growth and trends in energy were better than expected, but margins may remain pressured as a result of ongoing investments. Silber kept his Market Perform rating on Verisk.
CHEF Chefs' Warehouse
$19.45

-0.75 (-3.71%)

04/07/17
04/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. FedEx (FDX) initiated with a Buy at Loop Capital. 2. Apache (APA) initiated with a Hold at Stifel. 3. Symantec (SYMC) resumed with a Market Perform at Wells Fargo. 4. MidWestOne (MOFG) initiated with a Neutral at Piper Jaffray. 5. Chefs' Warehouse (CHEF) initiated with a Buy at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/17
LOOP
05/15/17
INITIATION
Target $18
LOOP
Buy
Chefs' Warehouse initiated with a Buy at Loop Capital
Loop Capital analyst Andrew Wolf started Chefs' Warehouse with a Buy rating and $18 price target. The analyst views the company as well positioned now that its protein segment has stabilized.
11/13/17
BMOC
11/13/17
UPGRADE
BMOC
Outperform
Chefs' Warehouse upgraded to Outperform from Market Perform at BMO Capital
11/13/17
BMOC
11/13/17
UPGRADE
Target $23
BMOC
Outperform
Chefs' Warehouse upgraded to Outperform at BMO on improving expense leverage
As reported earlier, BMO Capital analyst Kelly Bania upgraded Chefs' Warehouse to Outperform from Market Perform and raised her price target to $23 from $18. Bania says she believes that the company can reach at least a 6% EBITDA margin in the coming years relative to 4.9% in 2017, saying the progress is more realistic given the potential for improving expense leverage. The analyst also attributes the price target revision to the accretive impact of the Fells Point acquisition.
FLR Fluor
$58.04

0.41 (0.71%)

01/18/18
01/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Matthew Fassler saying selling consumables to middle-income consumers in small markets remains a compelling strategic position. 2. Hertz (HTZ) upgraded to Outperform from Neutral at Macquarie with analyst Hamzah Mazari saying he is more bullish on 2018 rental car pricing given fleet cutting by Enterprise, the positive impact on corporate travel from tax reform, and the potential US infrastructure bill creating excess demand. For Hertz specifically. 3. Alarm.com (ALRM) upgraded to Buy from Hold at Jefferies analyst John DiFucci saying Alarm.com is at the forefront of the trend towards connected homes and devices. 4. PPL Corp. (PPL) upgraded to Buy from Hold at Deutsche Bank with analyst Jonathan Arnold saying the current valuation is "too cheap to ignore," and U.K. energy regulator Ofgem failing to implement a mid-period review of RIIO-ED1 offers "decent prospects for a near-term re-rating catalyst." 5. Fluor (FLR) upgraded to Outperform from Neutral at Credit Suisse with analyst Jamie Cook saying investors will gravitate back to Engineering & Construction stocks as fundamentals for the group are improving. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/18
FBCO
01/18/18
UPGRADE
Target $71
FBCO
Outperform
Credit Suisse upgrades Fluor to Outperform with $71 price target
Credit Suisse analyst Jamie Cook upgraded Fluor to Outperform from Neutral and raised his price target for the shares to $71 from $43. The analyst says investors will gravitate back to Engineering & Construction stocks as fundamentals for the group are improving. Fluor will be the "go-to name," viewed as a higher quality bellwether with a diverse end market offering, Cook tells investors in a research note.
01/18/18
FBCO
01/18/18
UPGRADE
FBCO
Outperform
Fluor upgraded to Outperform from Neutral at Credit Suisse
01/03/18
BARD
01/03/18
UPGRADE
Target $61
BARD
Outperform
Fluor upgraded to Outperform at Baird
As reported previously, Baird analyst Andrew Wittmann upgraded Fluor to Outperform from Neutral citing better fundamentals, strengthening end-markets, and a bottom in commodity investment. Wittmann raised his price target to $61 from $48 on Fluor shares.
RAS RAIT Financial
$0.44

-0.031 (-6.56%)

08/15/17
08/15/17
DOWNGRADE
Target $1.25

Neutral
RAIT Financial downgraded to Neutral with $1.25 target at FBR Capital
FBR Capital analyst Jessica Levi-Ribner downgraded RAIT Financial Trust to Neutral from Buy and cut her price target for the shares to $1.25 from $3. While the valuation is "compelling" at current levels, the company's path forward is "too bumpy for now," Levi-Ribner tells investors in an intraday research note.
08/15/17
08/15/17
DOWNGRADE

Neutral
RAIT Financial downgraded to Neutral from Buy at FBR Capital
08/09/17
JMPS
08/09/17
DOWNGRADE
JMPS
Underperform
RAIT Financial downgraded after Q2 miss at JMP Securities
As noted earlier, JMP Securities downgraded RAIT to Underperform from Market Perform. Analyst Steven DeLaney downgraded the stock after the company reported a higher than expected Q2 loss. Target $1.
08/09/17
JMPS
08/09/17
DOWNGRADE
JMPS
Underperform
RAIT Financial downgraded to Underperform from Market Perform at JMP Securities
EVBN Evans Bancorp
$40.95

-1.55 (-3.65%)

09/29/17
HOVD
09/29/17
DOWNGRADE
HOVD
Market Perform
Evans Bancorp downgraded to Market Perform from Outperform at Hovde Group
CATM Cardtronics
$24.69

-0.59 (-2.33%)

01/18/18
BOFA
01/18/18
DOWNGRADE
BOFA
Underperform
Cardtronics downgraded to Underperform on reduced profitability at BofA/Merrill
As previously reported, BofA/Merrill downgraded Cardtronics to Neutral from Buy and lowered its price target to $23 from $29. Analyst David Ridley-Lane said Cardtronics is becoming a smaller and less profitable as it shrinks its ATM footprint and said shares are trading at a premium following the recent "relief" rally.
09/26/17
LSCM
09/26/17
DOWNGRADE
LSCM
Hold
Cardtronics downgraded to Hold from Buy at Lake Street
01/24/18
WELS
01/24/18
UPGRADE
Target $29
WELS
Outperform
Cardtronics upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Timothy Willi upgraded Cardtronics to Outperform and raised his price target for the shares to $29 from $20. The analyst views the stock's risk/reward as favorable at current "trough" valuation levels. He believes the company's cash flow generation limits downside risk.
01/18/18
BOFA
01/18/18
DOWNGRADE
BOFA
Underperform
Cardtronics downgraded to Underperform from Neutral at BofA/Merrill
LC LendingClub
$4.13

0.18 (4.56%)

12/08/17
MSCO
12/08/17
NO CHANGE
Target $6
MSCO
Overweight
LendingClub expectations should be more aligned after event, says Morgan Stanley
Morgan Stanley analyst James Faucette noted that LendingClub's expectations communicated at its investor day point to more modest topline growth and margins than bulls were hoping, though he also believes providing these targets should align Street and investor expectations "far better than they have been," which he sees as a clear positive. He trimmed his price target on LendingClub shares to $6 from $6.50 following the event and keeps an Overweight rating on the stock.
12/11/17
MAXM
12/11/17
NO CHANGE
Target $6
MAXM
Buy
LendingClub price target lowered to $6 from $8 at Maxim
Maxim analyst Michael Diana lowered his price target on LendingClub to $6 from $8, citing the company's below-consensus FY18 EBITDA guidance of $75M-90M at its first investor day last week. Diana keeps his Buy rating on LendingClub thanks to longer-term positives, including increasing penetration of unsecured personal loan market for credit card debt refinancing, rising "predictability" of the company's credit algorithms, and the "virtuous cycle" of predictable credit leading to lower rates for borrowers. The analyst says that 2019, rather than 2018, will now likely be the year highlighted by rising revenue from new products and operating efficiency.
12/08/17
OPCO
12/08/17
NO CHANGE
Target $5
OPCO
Outperform
LendingClub risk/reward remains favorable, says Oppenheimer
Oppenheimer analyst Jed Kelly lowered his price target for LendingClub to $5 from $6.25 after the company guided 2018 below expectations. The analyst, however, believes the risk/reward remains favorable amid a rebase in Street expectations and the stock's selloff. He keeps an Outperform rating on LendingClub.
01/05/18
SBSH
01/05/18
NO CHANGE
Target $1400
SBSH
Buy
Citi names Amazon top Internet pick for 2018, ups target to $1,400
Citi analyst Mark May remains bullish on the consumer Internet sector, especially over the near term. The analyst believes a "positive, tax reform fueled, business climate" should benefit the end-markets of the companies in the space. After outperformance in 2017, however, he recommends being more selective in 2018. Amazon.com (AMZN) moves up a spot to become his top-ranked pick for 2018. May sees the combination of greater than 30% sales growth, margin expansion and the current valuation as a "compelling mix." He raised his price target for Amazon shares to $1,400 from $1,250. May's most- to least-favored stocks under coverage, in order, are: Amazon, Expedia (EXPE), Facebook (FB), Priceline (PCLN), Alphabet (GOOGL), eBay (EBAY), Yelp (YELP), Twitter (TWTR), TripAdvisor (TRIP), Netflix (NFLX), GrubHub (GRUB), GoDaddy (GDDY), Despegar.com (DESP), trivago (TRVG), LendingClub (LC), Wayfair (W), Snap (SNAP), Zillow (ZG), Blue Apron (APRN) and Roku (ROKU), which he downgraded this morning to Sell.
BYD Boyd Gaming
$37.60

0.26 (0.70%)

01/18/18
JEFF
01/18/18
INITIATION
Target $34
JEFF
Hold
Boyd Gaming initiated with a Hold at Jefferies
Jefferies analyst David Katz initiated coverage of the casino industry, starting Boyd Gaming with a Hold rating and $34 price target.
01/05/18
BOFA
01/05/18
UPGRADE
BOFA
Buy
Boyd Gaming upgraded to Buy from Neutral at BofA/Merrill
01/05/18
01/05/18
UPGRADE
Target $42

Buy
Boyd Gaming upgraded to Buy on accelerating growth, recovery at BofA/Merrill
As previously reported, BofA/Merrill upgraded Boyd Gaming to Buy from Neutral and raised its price target to $42 from $34. Analyst Shaun Kelley views valuation as attractive and sees multiple expansion opportunities driven by solid, potentially accelerating, top-line growth, promotional discipline and rationalization leading to improved margins, and optionality from M&A and real estate flexibility.
02/05/18
DBAB
02/05/18
NO CHANGE
Target $47
DBAB
Buy
Boyd Gaming price target raised to $47 from $39 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli raised his price target for Boyd Gaming to $47 ahead of the company's Q4 results. The analyst sees portfolio improvements and strength in the Las Vegas locals market driving "sound" Q4 results. The analyst believes the company's portfolio is well positioned for longer term growth and keeps a Buy rating on the shares.
TXRH Texas Roadhouse
$56.91

-1.07 (-1.85%)

01/16/18
BTIG
01/16/18
NO CHANGE
Target $67
BTIG
Buy
Texas Roadhouse price target raised to $67 from $56 at BTIG
BTIG analyst Peter Saleh raised his price target on Texas Roadhouse to $67 on expectation of positive impact from the U.S. tax reform and the company's strong sales momentum. Given that Texas Roadhouse has already invested in its salesforce to reduce turnover, the analyst contends, the extra cash from the lower tax rates will flow to earnings. Saleh keeps his Buy rating, forecasting strong initial comps in 2018 amid easy comparisons to last year.
01/23/18
FBCO
01/23/18
UPGRADE
FBCO
Outperform
Texas Roadhouse upgraded to Outperform from Neutral at Credit Suisse
01/23/18
01/23/18
UPGRADE
Target $65

Outperform
Texas Roadhouse upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Jason West upgraded Texas Roadhouse to Outperform from Neutral as he believes EPS forecasts are too low and sees potential for multiple expansion. The analyst also raised his price target on the shares to $65 from $48.
01/24/18
MAXM
01/24/18
NO CHANGE
Target $65
MAXM
Buy
Texas Roadhouse price target raised to $65 from $60 at Maxim
Maxim analyst Stephen Anderson raised his price target on Texas Roadhouse to $65 ahead of next month's Q4 earnings report. The analyst sees a better than expected blended comps and also sees room for more margin upside this year. Anderson keeps his Buy rating on Texas Roadhouse, adding there is more benefit to come from lower corporate tax rates and accelerated buybacks.
PTLA Portola Pharmaceuticals
$48.22

0.53 (1.11%)

12/29/17
OPCO
12/29/17
NO CHANGE
Target $80
OPCO
Outperform
Portola 14% selloff brings buying opportunity, says Oppenheimer
Oppenheimer analyst Jay Olson believes the 14% pullback in Portola Pharmaceuticals since the company disclosed on December 22 a three-month delay to the AndexXa FDA action date presents a buying opportunity. The decline is unwarranted as Portola plans to launch two new drugs in 2018, each with sales potential exceeding $1B at peak, Olson tells investors in a research note titled "Stop the Bleeding! Overreaction to AndexXa Delay Creates Buying Opportunity." The analyst sees the three-month delay to AndexXa as "essentially immaterial" to his outlook for the company. Olson reiterates an Outperform rating on Portola Pharmaceuticals with an $80 price target. The stock closed yesterday down 57c to $47.25.
12/28/17
SBSH
12/28/17
NO CHANGE
Target $78
SBSH
Buy
Citi still expects FDA approval for Portola despite 90 day delay
After speaking to management, Citi analyst Yigal Nochomovitz expects Portola Pharmaceuticals' AndexXa to be approved on or before the new FDA action date of May 4, 2018. The additional data, which led to the 90 day delay, pertain, at least in part, to an update on thrombotic events in ANNEXA-4 since the last cut, Nochomovitz tells investors in a research note. The analyst believes the FDA may be using the new data submitted to refine label language on when to recommend restarting anti-coagulation. He says he would be "very surprised" if the FDA cannot reach a positive decision without a panel hearing. Nochomovitz keeps a Buy rating on Portola with a $74 price target. The stock closed yesterday down 2% to $47.82.
01/22/18
OPCO
01/22/18
NO CHANGE
OPCO
Neurocrine, CymaBay could benefit from increased M&A, says Oppenheimer
Oppenheimer analyst Jay Olson notes that driven by tax reform and cash repatriation, Biotech investors expect increased M&A activity. The analyst believes tax reform with cash repatriation will increase firepower of potential buyers, and points out that managements stated interest in targets with strategic fit. In his coverage universe, Olson believes Neurocrine (NBIX), Portola Pharmaceuticals (PTLA) and CymaBay (CBAY) shares could benefit from increased M&A based on their therapeutic areas and strategic fit.
02/20/18
SBSH
02/20/18
NO CHANGE
Target $78
SBSH
Buy
Citi views today's CHMP agenda as positive for Portola Pharmaceuticals
The European Medicines Agency's Committee for Medicinal Products for Human Use yesterday posted its agenda for the upcoming week of regulatory workflow, Citi analyst Yigal Nochomovitz tells investors in a research note. Included are oral explanations on February 20 for both Portola Pharmaceuticals' AndexXa and Bevyxxa. It also seems like the CHMP could render a formal opinion on AndexXa today, and for Bevyxxa in March, Nochomovitz writes. The analyst notes that while the apparent timing of the oral hearing and formal opinion for AndexXa on the same day is unusual, his initial read is that this is a positive. He keeps a Buy rating on Portola shares with a $78 price target.

TODAY'S FREE FLY STORIES

UGP

Ultrapar

$11.42

0.375 (3.40%)

09:33
07/23/18
07/23
09:33
07/23/18
09:33
Downgrade
Ultrapar rating change  »

Ultrapar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZZ

Cosan

$8.32

0.105 (1.28%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Downgrade
Cosan rating change  »

Cosan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LPNT

LifePoint

$47.85

-0.75 (-1.54%)

, CYH

Community Health

$2.72

-0.055 (-1.99%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Recommendations
LifePoint, Community Health, Apollo Global, HCA Healthcare analyst commentary  »

Deal activity could pick…

LPNT

LifePoint

$47.85

-0.75 (-1.54%)

CYH

Community Health

$2.72

-0.055 (-1.99%)

APO

Apollo Global

$35.39

-0.22 (-0.62%)

HCA

HCA Healthcare

$108.01

0.31 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Jul

  • 27

    Jul

  • 02

    Aug

  • 22

    Aug

BIDU

Baidu

$260.00

-2.32 (-0.88%)

09:31
07/23/18
07/23
09:31
07/23/18
09:31
Downgrade
Baidu rating change  »

Baidu downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

SLM

Sallie Mae

$11.71

-0.11 (-0.93%)

, CHGG

Chegg

$29.07

-0.07 (-0.24%)

09:31
07/23/18
07/23
09:31
07/23/18
09:31
Hot Stocks
Sallie Mae, Chegg introduce enhanced Study Starter benefit »

Sallie Mae (SLM) and…

SLM

Sallie Mae

$11.71

-0.11 (-0.93%)

CHGG

Chegg

$29.07

-0.07 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

09:30
07/23/18
07/23
09:30
07/23/18
09:30
Hot Stocks
Trump calls U.S. Post Office Amazon's 'delivery boy' at fraction of cost »

President Trump tweeted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

HAL

Halliburton

$45.23

0.26 (0.58%)

09:29
07/23/18
07/23
09:29
07/23/18
09:29
Hot Stocks
Halliburton says sees international business better in 2H18 »

Says seeing ramp up in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BV

BrightView

$21.95

0.14 (0.64%)

09:29
07/23/18
07/23
09:29
07/23/18
09:29
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:28
07/23/18
07/23
09:28
07/23/18
09:28
Hot Stocks
Halliburton says sees Q3 effective tax rate approximately 20% »

Says expects go generate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BSX

Boston Scientific

$33.77

0.06 (0.18%)

, SYK

Stryker

$174.33

1.44 (0.83%)

09:26
07/23/18
07/23
09:26
07/23/18
09:26
Recommendations
Boston Scientific, Stryker analyst commentary  »

Boston Scientific price…

BSX

Boston Scientific

$33.77

0.06 (0.18%)

SYK

Stryker

$174.33

1.44 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 14

    Aug

  • 15

    Aug

HAS

Hasbro

$94.02

0.38 (0.41%)

09:26
07/23/18
07/23
09:26
07/23/18
09:26
Hot Stocks
Hasbro says 30% of manufacturing is outside of China »

Says biggest percentage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BV

BrightView

$21.95

0.14 (0.64%)

09:23
07/23/18
07/23
09:23
07/23/18
09:23
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

, AUDVF

Audi AG

$0.00

(0.00%)

09:22
07/23/18
07/23
09:22
07/23/18
09:22
Periodicals
VW board member wary of 'humiliating' Audi's Stadler, FT reports »

Hiltrud Werner, a top…

VLKAY

Volkswagen

$0.00

(0.00%)

AUDVF

Audi AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$33.77

0.06 (0.18%)

09:21
07/23/18
07/23
09:21
07/23/18
09:21
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 14

    Aug

  • 15

    Aug

HAL

Halliburton

$45.23

0.26 (0.58%)

09:21
07/23/18
07/23
09:21
07/23/18
09:21
Earnings
Halliburton says sees Q3 earnings 'similar' to Q2 »

Says temporary challenges…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

09:20
07/23/18
07/23
09:20
07/23/18
09:20
General news
U.S. Sentiment Strength Extends into July: »

U.S. Sentiment Strength…

MU

Micron

$55.01

-1.2 (-2.13%)

, QCOM

Qualcomm

$58.62

-0.7 (-1.18%)

09:19
07/23/18
07/23
09:19
07/23/18
09:19
Recommendations
Micron, Qualcomm, AMD, Intel, Nvidia, Microchip, Texas Instruments, Marvell, Analog Devices, Cypress Semiconductor analyst commentary  »

Tariff uncertainty a…

MU

Micron

$55.01

-1.2 (-2.13%)

QCOM

Qualcomm

$58.62

-0.7 (-1.18%)

AMD

AMD

$16.49

-0.22 (-1.32%)

INTC

Intel

$51.92

-0.09 (-0.17%)

NVDA

Nvidia

$250.87

-1.15 (-0.46%)

MCHP

Microchip

$94.39

-0.46 (-0.48%)

TXN

Texas Instruments

$114.99

0.34 (0.30%)

MRVL

Marvell

$21.85

0.14 (0.64%)

ADI

Analog Devices

$97.81

-0.46 (-0.47%)

CY

Cypress Semiconductor

$17.06

-0.09 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 07

    Aug

  • 14

    Aug

  • 16

    Aug

HAL

Halliburton

$45.23

0.26 (0.58%)

09:18
07/23/18
07/23
09:18
07/23/18
09:18
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

HAL

Halliburton

$45.23

0.26 (0.58%)

09:18
07/23/18
07/23
09:18
07/23/18
09:18
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
07/23/18
07/23
09:18
07/23/18
09:18
Options
Overnight activity included 89 trades in SPX and 3 trades in VIX »

89 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:17
07/23/18
07/23
09:17
07/23/18
09:17
Hot Stocks
Halliburton says expects international markets to improve in coming quarters »

Says "better…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

MSFT

Microsoft

$106.29

1.59 (1.52%)

09:16
07/23/18
07/23
09:16
07/23/18
09:16
Conference/Events
Microsoft to hold a summit »

Microsoft Business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 08

    Aug

  • 04

    Sep

HAL

Halliburton

$45.23

0.26 (0.58%)

09:13
07/23/18
07/23
09:13
07/23/18
09:13
Hot Stocks
Halliburton says activity improved in all geographic markets in Q2 »

Says mindful of of impact…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

09:13
07/23/18
07/23
09:13
07/23/18
09:13
General news
Trump is 'very happy,' says 'Japan is happy, all of Asia is happy' »

President Trump just…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.